| Title | Parties | Law Firm | Date | Gov Law | |
| ALEXZA PHARMACEUTICALS, INC. WARRANT dated as of February , 2012 |
 ALEXZA PHARMACEUTICALS INC.
ALEXZA PHARMACEUTICALS, INC
| Unavailable | 2/12 | New York |
|
| Made this 9th day of March, 2011, between Great Spaces, LLC, Landlord, and Amerisure Pharmaceuticals, LLC, Tenant |
SUNPEAKS VENTURES, INC.
Amerisure Pharmaceuticals, LLC
Great Spaces, LLC
| Unavailable | 2/12 | Unavailable |
|
| CERTIFICATE OF AMENDMENT OF THE CERTIFICATE OF INCORPORATION OF RADIENT PHARMACEUTICALS CORP |
RADIENT PHARMACEUTICALS CORP
Radient Pharmaceuticals Corporation
| Unavailable | 1/12 | Unavailable |
|
| CERTIFICATE OF DESIGNATION OF SERIES A CONVERTIBLE PREFERRED STOCK OF TRANSDEL PHARMACEUTICALS, INC |
IMPRIMIS PHARMACEUTICALS, INC.
Principal Executive Officer, Principal Financial
TRANSDEL PHARMACEUTICALS, INC
| Unavailable | 12/11 | Unavailable |
|
| SYNERGY PHARMACEUTICALS, INC. UNIT AGENCY AGREEMENT |
SYNERGY PHARMACEUTICALS, INC.
1717 Arch Street, Suite 1300, Philadelphia, PA
Broadridge Corporate Issuer Solutions, Inc
Synergy Pharmaceuticals, Inc
| Reed Smith | 12/11 | New York |
|
| SYNERGY PHARMACEUTICALS, INC. WARRANT AGENCY AGREEMENT |
SYNERGY PHARMACEUTICALS, INC.
1717 Arch Street, Suite 1300, Philadelphia, PA
Broadridge Corporate Issuer Solutions, Inc
Synergy Pharmaceuticals, Inc
| Reed Smith | 12/11 | New York |
|
| ARENA PHARMACEUTICALS, INC. ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF [ ], 20 SENIOR DEBT SECURITIES TABLE OF CONTENTS(1) |
ARENA PHARMACEUTICALS INC
ARENA PHARMACEUTICALS, INC
| Unavailable | 11/11 | Delaware |
|
| ARENA PHARMACEUTICALS, INC. AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF [ ], 20 SUBORDINATED DEBT SECURITIES TABLE OF CONTENTS(1) |
ARENA PHARMACEUTICALS INC
ARENA PHARMACEUTICALS, INC
| Unavailable | 11/11 | Delaware |
|
| OPTIMER PHARMACEUTICALS, INC. and , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS |
OPTIMER PHARMACEUTICALS INC
OPTIMER PHARMACEUTICALS, INC
| Unavailable | 11/11 | New York |
|
| OPTIMER PHARMACEUTICALS, INC. and , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS |
OPTIMER PHARMACEUTICALS INC
OPTIMER PHARMACEUTICALS, INC
| Unavailable | 11/11 | New York |
|
| OPTIMER PHARMACEUTICALS, INC. and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS |
OPTIMER PHARMACEUTICALS INC
OPTIMER PHARMACEUTICALS, INC
| Unavailable | 11/11 | New York |
|
| OPTIMER PHARMACEUTICALS, INC. ISSUER AND [TRUSTEE], TRUSTEE |
OPTIMER PHARMACEUTICALS INC
OPTIMER PHARMACEUTICALS, INC
| Unavailable | 11/11 | Delaware |
|
| OPTIMER PHARMACEUTICALS, INC. AND [TRUSTEE], TRUSTEE |
OPTIMER PHARMACEUTICALS INC
OPTIMER PHARMACEUTICALS, INC
| Unavailable | 11/11 | Delaware |
|
| FORM OF SUBORDINATED INDENTURE Between ONCOGENEX PHARMACEUTICALS, INC. and , AS TRUSTEE Dated as |
ONCOGENEX PHARMACEUTICALS, INC.
ONCOGENEX PHARMACEUTICALS, INC
| Unavailable | 11/11 | New York |
|
| FORM OF SENIOR INDENTURE BETWEEN ONCOGENEX PHARMACEUTICALS, INC. AND , AS TRUSTEE Dated as |
ONCOGENEX PHARMACEUTICALS, INC.
ONCOGENEX PHARMACEUTICALS, INC
| Unavailable | 11/11 | New York |
|
| Alexza Pharmaceuticals Announces Submission of European Marketing Authorization Application for Adasuve® (Staccato® Loxapine) Application seeks European Marketing Approval for ADASUVE for the rapid control of agitation in adult patients with schizophrenia or bipolar disorder |
ALEXZA PHARMACEUTICALS INC.
Alexza Pharmaceuticals, Inc
| Unavailable | 10/11 | Unavailable |
|
| ENDO PHARMACEUTICALS REPORTS STRONG THIRD-QUARTER FINANCIAL RESULTS AND REAFFIRMS 2011 FINANCIAL GUIDANCE |
ENDO PHARMACEUTICALS HOLDINGS INC
ENDO PHARMACEUTICALS REPORTS STRONG THIRD-QUARTER FINANCIAL RESULTS AND REAFFIRMS 2011 FINANCIAL
| Unavailable | 10/11 | Unavailable |
|
| ASSET PURCHASE AGREEMENT by and among AVANIR PHARMACEUTICALS, |
AZUR PHARMA PUBLIC LTD CO
ALAMO PHARMACEUTICALS, LLC
Avanir Pharmaceuticals
Azur Pharma Inc
Azur Pharma International III Limited
| Latham Watkins;Cahill Gordon | 10/11 | New York |
|
| ASSET PURCHASE AGREEMENT BETWEEN ELAN PHARMACEUTICALS, INC. AND AZUR PHARMA INTERNATIONAL LIMITED |
AZUR PHARMA PUBLIC LTD CO
Azur Pharma International Limited
ELAN PHARMACEUTICALS, INC
| Cahill Gordon;Mayer Brown | 10/11 | New York |
|
| MOLINA HEALTHCARE REPORTS THIRD QUARTER 2011 RESULTS |
MOLINA HEALTHCARE INC
Molina Healthcare, Inc
| Unavailable | 10/11 | Unavailable |
|
| Oramed Pharmaceuticals Chosen to Present at the Diabetes Technology Meeting (October 27-29, 2011; San Francisco, CA) |
ORAMED PHARMACEUTICALS INC.
Oramed Pharmaceuticals Inc
| Unavailable | 10/11 | Unavailable |
|
| MASTER TERMS AND CONDITIONS FOR BASE WARRANTS ISSUED BY REGENERON PHARMACEUTICALS, INC |
REGENERON PHARMACEUTICALS INC
Credit Suisse AG
REGENERON PHARMACEUTICALS, INC
| Unavailable | 10/11 | New York |
|
| MASTER TERMS AND CONDITIONS FOR BASE WARRANTS ISSUED BY REGENERON PHARMACEUTICALS, INC |
REGENERON PHARMACEUTICALS INC
Citibank, NA
Regeneron Pharmaceuticals, Inc
| Unavailable | 10/11 | New York |
|
| REGENERON PHARMACEUTICALS, INC. 1.875% CONVERTIBLE SENIOR NOTES DUE 2016 |
REGENERON PHARMACEUTICALS INC
CEDE & CO
GLOBAL NOTE SHALL BE LIMITED
NO AFFILIATE
US INTERNAL REVENUE CODE PLEASE CONTACT INVESTOR RELATIONS DEPARTMENT, REGENERON PHARMACEUTICALS, INC
Wells Fargo Bank, National Association
| Unavailable | 10/11 | Unavailable |
|
| MASTER TERMS AND CONDITIONS FOR BASE WARRANTS ISSUED BY REGENERON PHARMACEUTICALS, INC |
REGENERON PHARMACEUTICALS INC
Goldman, Sachs & Co
REGENERON PHARMACEUTICALS, INC
| Unavailable | 10/11 | New York |
|